Nordihydroguaiartic derivatives for use in treatment of tumors

Details Nordihydroguaiartic derivatives for use in treatment of tumors Nordihydroguaiartic derivatives for use in treatment of tumors

2005-10-25

2005-10-25

Jones, Dwayne (Department: 1614)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carboxylic acid esters

C560S138000, C560S147000, C560S155000, C560S174000, C560S179000, C560S190000

Reexamination Certificate

active

06958411

ABSTRACT:
Nordihydroguaiaretic acid derivatives and methods of use thereof for the treatment of tumors.

REFERENCES:
patent: 4425327 (1984-01-01), Moller et al.
patent: 4774229 (1988-09-01), Jordan
patent: 4880637 (1989-11-01), Jordan
patent: 5008294 (1991-04-01), Neiss et al.
patent: 5276060 (1994-01-01), Neiss et al.
patent: 5559149 (1996-09-01), Clum et al.
patent: 5827898 (1998-10-01), Khandwala et al.
patent: 5837252 (1998-11-01), Sinnott et al.
patent: 5965616 (1999-10-01), Wang et al.
patent: 6071949 (2000-06-01), Mulshine et al.
patent: 6214874 (2001-04-01), Huang et al.
Chen et al., Antiviral Activities of Methylated Nordihydrogaiaretic Acids. 2. Targeting Herpes Simplex Virus Replication by the Mutation Insensitive Transcription Inhibitor Tetra-O-methyl-NDGA, Journal of Medicinal Chemistry, 1998, vol. 41, No. 16, pp. 3001-3007.
Gnabre et al., Isolation of Anti-HIV-1 Lignans fromLarrea tridentataby Counter-Current Chromatography, Journal of Chromatography A., 719, 1995, pp. 1-12.
Gnabre et al., Characterization of Anti-HIV Lignans fromLarrea tridentata,Tetrahedron, 1995, vol. 51, No. 45, pp. 12203-12210.
Gnabre et al., Inhibition of Human Immunodeficiency Virus Type 1 Transcription and Replication by DNA Sequence-Selective Plant Lignans, Proc. Natl. Acad. Sci. USA, 1995, vol. 92, pp. 11239-11243.
Gisvold et al., Lignans fromLarrea divaricata,Journal of Pharmaceutical Sciences, 1974, vol. 63, No. 12, pp. 1905-1907.
Hwu et al., Antiviral Activities of Methylated Nordihydroguaiaretic Acids. 1. Synthesis, Structure Identification, and Inhibition of Tat-Regulated HIV Transactivation, J. Med. Chem, 1998, vol. 41, No. 16, pp. 2994-3000.
Huang et al., Regulation of HIV Promoter Activities in Human Embryonal Carcinoma Cells, NTERA-2, Gene Regulation and AIDS, 1989, pp. 147-160.

Affiliated with

Also associated with

Rating

Nordihydroguaiartic derivatives for use in treatment of tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nordihydroguaiartic derivatives for use in treatment of tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nordihydroguaiartic derivatives for use in treatment of tumors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3463960